文献速递烧伤创面修复

RECELL系统联合网状刃厚皮片减少供皮区治疗混合深度烧伤的安全性与有效性

Demonstration of the safety and effectiveness of the RECELL® System combined with split-thickness meshed autografts for the reduction of donor skin to treat mixed-depth burn injuries.
PubMed 文献 · Burns · 2018-12-19

一项多中心、前瞻性、自身对照随机临床试验纳入30例混合深度烧伤(含全层)患者,比较RECELL联合更宽网孔刃厚皮片与标准网状刃厚皮片的疗效。8周时RECELL组愈合率92%、对照组85%,达非劣效;供皮使用平均减少32%(p<0.001),达优效;两组安全性与次要结局相似。

要点

  • RECELL联合宽网孔刃厚皮片8周愈合率达92%,不劣于标准皮片移植的85%。
  • RECELL使平均供皮使用量显著减少32%(p<0.001),降低供皮区病损。
  • 该疗法适用于无融合真皮的混合深度烧伤,短期与长期愈合与标准皮片相当。

核心结论

  • RECELL联合宽网孔刃厚皮片是治疗无融合真皮混合深度烧伤安全有效的床旁疗法,愈合与标准皮片相当且显著减少供皮使用。

研究设计与样本

  • 多中心、前瞻性、自身对照、随机临床试验,纳入30例受试者,每例设1个对照区和1个RECELL治疗区。
  • 对照为标准网状刃厚皮片,RECELL治疗为RECELL联合比预设标准网孔更宽的网状刃厚皮片。
  • 疗效评估包括完全创面闭合、供皮使用、受试者满意度及治疗后1年瘢痕结局。

主要发现

  • 8周时对照区愈合85%,RECELL区愈合92%,确立RECELL治疗愈合的非劣效性。
  • 两组创面平均大小相似,但RECELL组平均供皮使用显著减少32%(p<0.001),确立减少供皮需求的优效性。
  • 次要有效性与安全性结局在两组间相似。

关键数值与推荐

  • RECELL系统用1cm²患者皮肤可治疗最多80cm²切除烧伤创面。
  • 8周完全愈合率:对照85% vs RECELL 92%。
  • 供皮使用平均减少32%(p<0.001)。

临床怎么用

  • 对无融合真皮的混合深度烧伤,可用RECELL联合更宽网孔刃厚皮片以扩大覆盖面积并减少供皮区获取。
  • 适用于需自体植皮但供皮有限的烧伤患者,床旁制备非培养自体细胞悬液。

局限性

  • 样本量为30例,属较小规模临床试验。
  • 研究为自身对照设计,随访至治疗后1年。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Split-thickness skin grafts (STSG) are the standard of care (SOC) for burns undergoing autografting but are associated with donor skin site morbidity and limited by the availability of uninjured skin. The RECELL® Autologous Cell Harvesting Device (RECELL® System, or RECELL) was developed for point-of-care preparation and application of a suspension of non-cultured, disaggregated, autologous skin cells, using 1cm2 of the patient's skin to treat up to 80cm2 of excised burn. METHODS: A multi-center, prospective, within-subject controlled, randomized, clinical trial was conducted with 30 subjects to evaluate RECELL in combination with a more widely meshed STSG than a pre-defined SOC meshed STSG (RECELL treatment) for the treatment of mixed-depth burns, including full-thickness. Treatment areas were randomized to receive standard meshed STSG (Control treatment) or RECELL treatment, such that each subject had 1 Control and 1 RECELL treatment area. Effectiveness measures were assessed and included complete wound closure, donor skin use, subject satisfaction, and scarring outcomes out to one year following treatment. RESULTS: At 8 weeks, 85% of the Control-treated wounds were healed compared with 92% of the RECELL-treated wounds, establishing the non-inferiority of RECELL treatment for wound healing. Control-treated and RECELL-treated wounds were similar in mean size; however, mean donor skin use was significantly reduced by 32% with the use of RECELL (p<0.001), establishing the superiority of RECELL treatment for reducing donor skin requirements. Secondary effectiveness and safety outcomes were similar between the treatments. CONCLUSIONS: In combination with widely meshed STSG, RECELL is a safe and effective point-of-care treatment for mixed-depth burns without confluent dermis, achieving short- and long-term healing comparable to standard STSG, while significantly decreasing donor skin use.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Holmes JH, Molnar JA, Shupp JW, et al. Demonstration of the safety and effectiveness of the RECELL® System combined with split-thickness meshed autografts for the reduction of donor skin to treat mixed-depth burn injuries. Burns. 2018. PMID: 30578048. doi:10.1016/j.burns.2018.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。